Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptor

Marianne Benn, Børge G Nordestgaard, Jan Skov Jensen, Karin Skov Nilausen, Hans Meinertz, Anne Tybjaerg-Hansen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    16 Citationer (Scopus)

    Abstract

    Mutations in apolipoprotein B (APOB) may reduce binding of low density lipoprotein (LDL) to the LDL receptor and cause hypercholesterolemia. We showed that heterozygotes for a new mutation in APOB have hypobetalipoproteinemia, despite a reduced binding of LDL to the LDL receptor. APOB R3480P heterozygotes were identified among 9,255 individuals from the general population and had reduced levels of apoB-containing lipoproteins. Most surprisingly, R3480P LDL bound with lower affinity to the LDL receptor than non-carrier LDL in vitro, and these results were confirmed by turnover studies of LDL in vivo. In very low density lipoprotein (VLDL) turnover studies, the amount of VLDL converted to LDL in R3480P heterozygotes was substantially reduced, suggesting that this was the explanation for the hypobetalipoproteinemia observed in these individuals. Our findings emphasized the importance of combining in vitro studies with both human in vivo and population-based studies, as in vitro studies often have focused on very limited aspects of complex mechanisms taken out of their natural context.
    OriginalsprogEngelsk
    TidsskriftJournal of Biological Chemistry
    Vol/bind280
    Udgave nummer22
    Sider (fra-til)21052-60
    Antal sider9
    ISSN0021-9258
    DOI
    StatusUdgivet - 2005

    Citationsformater